Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (286)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
109
1.970
 Why?
Thyroidectomy
13
2019
60
1.810
 Why?
Thyroid Diseases
8
2019
27
1.430
 Why?
Parathyroidectomy
8
2018
46
1.280
 Why?
Parathyroid Neoplasms
5
2015
28
1.070
 Why?
Thyroid Gland
8
2017
75
1.070
 Why?
Parathyroid Hormone
8
2019
149
0.950
 Why?
Vitamin D Deficiency
5
2019
45
0.940
 Why?
Adenoma
4
2017
113
0.940
 Why?
Vitamin D
4
2015
88
0.810
 Why?
Fluorodeoxyglucose F18
6
2013
187
0.730
 Why?
Positron-Emission Tomography
7
2013
290
0.720
 Why?
Radiopharmaceuticals
7
2015
202
0.710
 Why?
Carcinoma, Papillary
4
2017
47
0.700
 Why?
Ambulatory Surgical Procedures
4
2014
54
0.680
 Why?
Hyperparathyroidism, Primary
4
2018
36
0.650
 Why?
Iodine Radioisotopes
4
2015
35
0.610
 Why?
Hyperparathyroidism
2
2015
31
0.590
 Why?
Megestrol Acetate
2
2007
17
0.520
 Why?
Parathyroid Diseases
2
2016
5
0.520
 Why?
Bone Density Conservation Agents
2
2007
74
0.510
 Why?
Nursing Homes
2
2007
111
0.500
 Why?
Incidental Findings
3
2013
39
0.480
 Why?
Proton Pump Inhibitors
1
2015
83
0.470
 Why?
Diphosphonates
1
2015
90
0.460
 Why?
Academic Medical Centers
2
2012
147
0.450
 Why?
Thyroglobulin
2
2013
7
0.450
 Why?
Aged
20
2017
9738
0.430
 Why?
Parathyroid Glands
5
2018
21
0.430
 Why?
Carcinoma, Medullary
2
2010
12
0.430
 Why?
Middle Aged
26
2017
12579
0.420
 Why?
Male
32
2019
25866
0.390
 Why?
Hypothyroidism
2
2011
56
0.380
 Why?
Retrospective Studies
14
2019
6274
0.380
 Why?
Postoperative Complications
5
2018
1030
0.370
 Why?
Calcitonin
2
2010
30
0.370
 Why?
Humans
49
2019
50419
0.360
 Why?
Carcinoma
2
2012
137
0.340
 Why?
Algorithms
1
2013
624
0.330
 Why?
Thyroid Nodule
3
2017
31
0.330
 Why?
Female
31
2019
27053
0.320
 Why?
Weight Loss
2
2009
245
0.310
 Why?
Aged, 80 and over
10
2017
3233
0.280
 Why?
Appetite Stimulants
1
2007
5
0.280
 Why?
Cachexia
1
2007
25
0.270
 Why?
Receptors, Estrogen
2
2005
132
0.270
 Why?
Teriparatide
1
2007
10
0.270
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.260
 Why?
Hypocalcemia
2
2016
12
0.250
 Why?
Calcium
3
2018
397
0.250
 Why?
Transcriptional Activation
2
2005
120
0.250
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.250
 Why?
Phenylurea Compounds
2
2015
15
0.240
 Why?
Hormones
1
2005
57
0.240
 Why?
Osteoporosis
1
2007
156
0.240
 Why?
Quinolines
2
2015
42
0.240
 Why?
Pituitary Gland
1
2005
85
0.230
 Why?
Receptors, Thyrotropin
2
2007
8
0.230
 Why?
Interleukin-6
1
2005
261
0.220
 Why?
NF-kappa B
1
2005
306
0.220
 Why?
Protein Kinase Inhibitors
2
2015
204
0.210
 Why?
Biopsy, Fine-Needle
5
2011
108
0.210
 Why?
Illinois
2
2013
10
0.200
 Why?
Treatment Outcome
8
2015
5265
0.200
 Why?
Adult
13
2017
13561
0.190
 Why?
Gene Expression Regulation
3
2005
948
0.190
 Why?
Aging
1
2005
692
0.170
 Why?
Young Adult
7
2015
4075
0.170
 Why?
Follow-Up Studies
3
2013
2231
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
 Why?
Postoperative Period
3
2015
171
0.150
 Why?
Thyroid Hormones
1
1998
20
0.150
 Why?
Receptors, Cytoplasmic and Nuclear
1
1998
66
0.150
 Why?
Receptors, Cell Surface
1
1998
117
0.150
 Why?
Preoperative Care
2
2018
170
0.140
 Why?
Vitamins
2
2018
65
0.140
 Why?
Patient Discharge
3
2016
318
0.140
 Why?
Intraoperative Complications
1
2019
112
0.140
 Why?
Insulin Resistance
2
2009
267
0.140
 Why?
Antineoplastic Agents
2
2015
1165
0.140
 Why?
United States
5
2015
5005
0.140
 Why?
Prospective Studies
2
2013
2378
0.140
 Why?
Predictive Value of Tests
3
2015
924
0.130
 Why?
Reoperation
1
2018
461
0.130
 Why?
Incidence
2
2011
1027
0.130
 Why?
Adolescent
5
2015
6453
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
22
0.120
 Why?
Creatinine
1
2015
142
0.120
 Why?
Costs and Cost Analysis
2
2014
90
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.120
 Why?
Lymph Nodes
1
2017
256
0.120
 Why?
Disease Progression
3
2015
825
0.120
 Why?
Molecular Targeted Therapy
1
2015
122
0.110
 Why?
Diagnosis, Differential
6
2018
1029
0.110
 Why?
Ambulatory Care
1
2016
243
0.110
 Why?
Neoplasm Metastasis
2
2015
230
0.110
 Why?
Hospitals, University
1
2014
75
0.110
 Why?
Child, Preschool
2
2013
3953
0.110
 Why?
Sensitivity and Specificity
2
2013
855
0.110
 Why?
Exercise
2
2009
513
0.110
 Why?
Liver
2
2009
1126
0.100
 Why?
Drug Administration Schedule
1
2013
373
0.100
 Why?
Hospitals, Teaching
1
2013
52
0.100
 Why?
Technetium
1
2012
9
0.100
 Why?
Preoperative Period
1
2012
46
0.100
 Why?
Administration, Oral
1
2013
438
0.100
 Why?
Patient Compliance
1
2013
232
0.100
 Why?
Radionuclide Imaging
1
2012
116
0.100
 Why?
Outpatients
1
2013
121
0.100
 Why?
Clinical Competence
2
2018
403
0.100
 Why?
Hospital Charges
1
2012
44
0.100
 Why?
Tumor Burden
1
2012
130
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Cost Savings
1
2012
58
0.100
 Why?
Prognosis
3
2015
1974
0.090
 Why?
Child
3
2013
6931
0.090
 Why?
Promoter Regions, Genetic
4
2007
455
0.090
 Why?
Ovariectomy
1
2012
115
0.090
 Why?
Immunohistochemistry
2
2012
955
0.090
 Why?
Obesity
2
2009
1123
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1369
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Checklist
1
2010
29
0.080
 Why?
Inpatients
1
2011
194
0.080
 Why?
Radiosurgery
1
2011
123
0.080
 Why?
Fatal Outcome
1
2010
197
0.080
 Why?
Databases, Factual
1
2013
676
0.080
 Why?
HeLa Cells
4
2005
257
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
35
0.080
 Why?
Ultrasonography
4
2015
434
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
32
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
General Surgery
1
2010
105
0.080
 Why?
Occupational Exposure
1
2010
113
0.080
 Why?
Blastomycosis
1
2008
62
0.070
 Why?
Symporters
1
2007
17
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Ovarian Neoplasms
1
2012
449
0.070
 Why?
Time Factors
3
2015
2933
0.070
 Why?
Severity of Illness Index
1
2011
976
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Whole Body Imaging
1
2007
26
0.070
 Why?
Adiposity
1
2009
137
0.070
 Why?
Base Sequence
3
2005
622
0.070
 Why?
DNA, Neoplasm
1
2007
144
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
11
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Drug Utilization Review
1
2006
23
0.070
 Why?
Drug Monitoring
1
2006
81
0.060
 Why?
Cross-Sectional Studies
2
2014
1601
0.060
 Why?
Head
1
2006
72
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
831
0.060
 Why?
Thyrotropin
3
2002
49
0.060
 Why?
Geriatrics
1
2006
47
0.060
 Why?
Body Mass Index
2
2009
674
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Neck
1
2006
100
0.060
 Why?
Proportional Hazards Models
1
2007
416
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
9
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Arkansas
2
2014
1974
0.060
 Why?
Faculty, Medical
1
2006
91
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Fractures, Bone
1
2006
110
0.060
 Why?
Survival Analysis
1
2007
658
0.060
 Why?
DNA Primers
1
2005
205
0.060
 Why?
Reproducibility of Results
3
2017
1181
0.060
 Why?
Internship and Residency
1
2010
443
0.060
 Why?
Nuclear Proteins
1
2005
235
0.050
 Why?
Protein Binding
1
2005
648
0.050
 Why?
Infant
1
2012
3648
0.050
 Why?
Proto-Oncogene Proteins c-jun
2
1993
77
0.050
 Why?
ROC Curve
2
2015
223
0.050
 Why?
Patient Selection
2
2018
257
0.050
 Why?
Intraoperative Period
2
2015
45
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
567
0.050
 Why?
Mutation
2
2017
1275
0.050
 Why?
Tongue Diseases
1
2001
7
0.050
 Why?
Choristoma
1
2001
24
0.050
 Why?
Receptors, Androgen
1
2001
45
0.040
 Why?
Tomography, X-Ray Computed
3
2012
1163
0.040
 Why?
DNA-Binding Proteins
2
1993
410
0.040
 Why?
Thalidomide
1
2002
375
0.040
 Why?
Transcription Factors
2
1993
561
0.040
 Why?
Cohort Studies
2
2015
1451
0.040
 Why?
Glucagon
2
2009
23
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
GTP-Binding Proteins
1
1998
94
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
48
0.040
 Why?
Autoantibodies
1
1998
114
0.040
 Why?
Risk Factors
1
2006
3712
0.040
 Why?
Pilot Projects
2
2010
694
0.040
 Why?
Methylene Blue
1
2017
9
0.030
 Why?
Lymphatic System
1
2017
13
0.030
 Why?
Societies, Medical
1
2018
189
0.030
 Why?
Animals, Genetically Modified
1
2017
46
0.030
 Why?
Coloring Agents
1
2017
67
0.030
 Why?
Mice, Inbred Strains
1
2017
159
0.030
 Why?
Insulin
2
2009
464
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
80
0.030
 Why?
Recurrence
1
2018
657
0.030
 Why?
Lymphatic Metastasis
1
2017
221
0.030
 Why?
Bone Density
1
2018
386
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
56
0.030
 Why?
Brachial Plexus
1
2015
11
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
64
0.030
 Why?
Signal Transduction
1
2001
1608
0.030
 Why?
Transplantation, Autologous
1
2015
480
0.030
 Why?
Neoplasm Staging
1
2015
738
0.030
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
24
0.020
 Why?
Mice
2
2017
5659
0.020
 Why?
Ribs
1
2010
15
0.020
 Why?
Thoracotomy
1
2010
35
0.020
 Why?
Mediastinal Neoplasms
1
2010
16
0.020
 Why?
Neck Dissection
1
2010
30
0.020
 Why?
Hypercalcemia
1
2010
33
0.020
 Why?
Feasibility Studies
1
2011
389
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
68
0.020
 Why?
Hospitalization
1
2014
677
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
967
0.020
 Why?
Glucose Tolerance Test
1
2009
58
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
227
0.020
 Why?
Absorptiometry, Photon
1
2009
155
0.020
 Why?
Postmenopause
1
2009
96
0.020
 Why?
Eye
1
2008
24
0.020
 Why?
Bone Neoplasms
1
2010
178
0.020
 Why?
Iodine
1
2007
9
0.020
 Why?
Methylation
1
2007
117
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
622
0.020
 Why?
Body Weight
1
2009
517
0.020
 Why?
Multiple Myeloma
1
2002
2990
0.020
 Why?
Overweight
1
2009
214
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Office Visits
1
2006
53
0.020
 Why?
Polymerase Chain Reaction
1
2007
447
0.020
 Why?
Animals
2
2017
13063
0.020
 Why?
Genetic Predisposition to Disease
1
2009
507
0.020
 Why?
Blood Glucose
1
2009
447
0.020
 Why?
Risk Assessment
1
2010
1268
0.020
 Why?
Lung
1
2008
493
0.010
 Why?
Thyrotropin-Releasing Hormone
2
1993
5
0.010
 Why?
Tetradecanoylphorbol Acetate
2
1993
47
0.010
 Why?
Transcription Factor Pit-1
2
1993
20
0.010
 Why?
Muscle, Skeletal
1
2009
786
0.010
 Why?
Thyroid Function Tests
1
2002
25
0.010
 Why?
Molecular Sequence Data
2
1993
760
0.010
 Why?
src Homology Domains
1
2001
9
0.010
 Why?
Airway Obstruction
1
2001
47
0.010
 Why?
Androgens
1
2001
71
0.010
 Why?
Cytoplasm
1
2001
92
0.010
 Why?
Estrogen Receptor beta
1
2001
56
0.010
 Why?
src-Family Kinases
1
2001
50
0.010
 Why?
Estrogen Receptor alpha
1
2001
90
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
154
0.010
 Why?
Deglutition Disorders
1
2001
77
0.010
 Why?
Cell Nucleus
1
2001
183
0.010
 Why?
Peptide Fragments
1
2001
208
0.010
 Why?
Binding Sites
1
2001
362
0.010
 Why?
Clinical Trials as Topic
1
2002
488
0.010
 Why?
Estrogens
1
2001
225
0.010
 Why?
Fibroblasts
1
2001
338
0.010
 Why?
Sex Factors
1
2001
718
0.010
 Why?
Osteoblasts
1
2001
463
0.010
 Why?
Osteoclasts
1
2001
427
0.010
 Why?
Apoptosis
1
2001
1092
0.010
 Why?
Oligodeoxyribonucleotides
1
1993
33
0.010
 Why?
Mutagenesis, Site-Directed
1
1993
96
0.010
 Why?
RNA, Messenger
1
1993
1085
0.010
 Why?
Cell Line
1
1993
997
0.010
 Why?
DNA
1
1993
534
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (286) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department